Etoricoxib, sold under the brand name Arcoxia, is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide...
13 KB (1,155 words) - 14:50, 7 September 2024
in the United States. In the European Union, celecoxib, parecoxib, and etoricoxib have been approved for use by the European Medicines Agency. Paracetamol...
42 KB (4,944 words) - 11:56, 4 April 2024
Clarithromycin Cotrimoxazole Doxycycline Fluconazole NSAIDs (e.g., ibuprofen, etoricoxib, naproxen) Phenytoin Pseudoephedrine Trimethoprim Drug eruption List of...
3 KB (182 words) - 04:21, 19 January 2024
gastrointestinal tract. Selectivity for COX-2 is the main feature of celecoxib, etoricoxib, and other members of this drug class. Because COX-2 is usually specific...
16 KB (1,779 words) - 11:08, 3 July 2024
substituent (SO2NH2) in para-position on one of the aryl rings while etoricoxib and rofecoxib have a methylsulfone (SO2CH3). The oxidation state on the...
37 KB (4,463 words) - 13:48, 4 June 2023
versions in general). These drugs (such as rofecoxib, celecoxib, and etoricoxib) are equally effective analgesics when compared with NSAIDs, but cause...
109 KB (5,859 words) - 22:39, 11 September 2024
there was no significant difference between NSAIDs. It was concluded that etoricoxib was more effective in reducing pain of AS, however due to small studies...
9 KB (883 words) - 17:11, 8 June 2024
from PubChem) Emylcamate Enflurane Entacapone Escitalopram Etomidate Etoricoxib Ethosuximide Levophacetoperane Phenprobamate Phenaglycodol Phenelzine...
26 KB (1,722 words) - 21:40, 3 October 2024
Sulindac Tolmetin Zomepirac ‡ COX-2 inhibitors Celecoxib (+tramadol) Etoricoxib Lumiracoxib ‡ Parecoxib Rofecoxib ‡ Valdecoxib ‡ Fenamates Flufenamic...
165 KB (17,242 words) - 10:41, 9 October 2024
University. At Merck, she became the chief statistician on the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme, a large international...
5 KB (253 words) - 06:14, 8 February 2023